These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
153 related articles for article (PubMed ID: 9395621)
1. An alternative medicine treatment for Parkinson's disease: results of a multicenter clinical trial. HP-200 in Parkinson's Disease Study Group. J Altern Complement Med; 1995; 1(3):249-55. PubMed ID: 9395621 [TBL] [Abstract][Full Text] [Related]
2. A multicenter, open-label, sequential study comparing preferences for carbidopa-levodopa orally disintegrating tablets and conventional tablets in subjects with Parkinson's disease. Nausieda PA; Pfeiffer RF; Tagliati M; Kastenholz KV; DeRoche C; Slevin JT Clin Ther; 2005 Jan; 27(1):58-63. PubMed ID: 15763606 [TBL] [Abstract][Full Text] [Related]
3. Double-blind trial of levodopa/carbidopa/entacapone versus levodopa/carbidopa in early Parkinson's disease. Hauser RA; Panisset M; Abbruzzese G; Mancione L; Dronamraju N; Kakarieka A; Mov Disord; 2009 Mar; 24(4):541-50. PubMed ID: 19058133 [TBL] [Abstract][Full Text] [Related]
4. Management of Parkinson's disease in Ayurveda: Medicinal plants and adjuvant measures. Pathak-Gandhi N; Vaidya AD J Ethnopharmacol; 2017 Feb; 197():46-51. PubMed ID: 27544001 [TBL] [Abstract][Full Text] [Related]
5. Quality of life in early Parkinson's disease treated with levodopa/carbidopa/entacapone. Fung VS; Herawati L; Wan Y; ; Mov Disord; 2009 Jan; 24(1):25-31. PubMed ID: 18846551 [TBL] [Abstract][Full Text] [Related]
6. A randomized double-blind multi-center trial of hydrogen water for Parkinson's disease: protocol and baseline characteristics. Yoritaka A; Abe T; Ohtsuka C; Maeda T; Hirayama M; Watanabe H; Saiki H; Oyama G; Fukae J; Shimo Y; Hatano T; Kawajiri S; Okuma Y; Machida Y; Miwa H; Suzuki C; Kazama A; Tomiyama M; Kihara T; Hirasawa M; Shimura H; Hattori N BMC Neurol; 2016 May; 16():66. PubMed ID: 27176725 [TBL] [Abstract][Full Text] [Related]
7. Ropinirole as an adjunct to levodopa in the treatment of Parkinson's disease: a 16-week bromocriptine controlled study. Im JH; Ha JH; Cho IS; Lee MC J Neurol; 2003 Jan; 250(1):90-6. PubMed ID: 12527999 [TBL] [Abstract][Full Text] [Related]
8. Ropinirole in the treatment of early Parkinson's disease: a 6-month interim report of a 5-year levodopa-controlled study. 056 Study Group. Rascol O; Brooks DJ; Brunt ER; Korczyn AD; Poewe WH; Stocchi F Mov Disord; 1998 Jan; 13(1):39-45. PubMed ID: 9452324 [TBL] [Abstract][Full Text] [Related]
9. Effect of antiparkinson drug HP-200 (Mucuna pruriens) on the central monoaminergic neurotransmitters. Manyam BV; Dhanasekaran M; Hare TA Phytother Res; 2004 Feb; 18(2):97-101. PubMed ID: 15022157 [TBL] [Abstract][Full Text] [Related]
10. Adding a dopamine agonist to preexisting levodopa therapy vs. levodopa therapy alone in advanced Parkinson's disease: a meta analysis. Talati R; Baker WL; Patel AA; Reinhart K; Coleman CI Int J Clin Pract; 2009 Apr; 63(4):613-23. PubMed ID: 19222614 [TBL] [Abstract][Full Text] [Related]
11. AFQ056 in Parkinson patients with levodopa-induced dyskinesia: 13-week, randomized, dose-finding study. Stocchi F; Rascol O; Destee A; Hattori N; Hauser RA; Lang AE; Poewe W; Stacy M; Tolosa E; Gao H; Nagel J; Merschhemke M; Graf A; Kenney C; Trenkwalder C Mov Disord; 2013 Nov; 28(13):1838-46. PubMed ID: 23853029 [TBL] [Abstract][Full Text] [Related]
12. Profile of levodopa-induced dyskinesia in patients of Parkinson's disease: a record based study. Choudhury S; Pradhan R; Paul P; Das M; Gupta A; Ghosh P; Chatterjee S Neurol Res; 2014 Sep; 36(9):841-6. PubMed ID: 24601722 [TBL] [Abstract][Full Text] [Related]
13. Treatment of end-of-dose wearing-off in parkinson's disease: stalevo (levodopa/carbidopa/entacapone) and levodopa/DDCI given in combination with Comtess/Comtan (entacapone) provide equivalent improvements in symptom control superior to that of traditional levodopa/DDCI treatment. Brooks DJ; Agid Y; Eggert K; Widner H; Ostergaard K; Holopainen A; Eur Neurol; 2005; 53(4):197-202. PubMed ID: 15970632 [TBL] [Abstract][Full Text] [Related]
14. Mucuna pruriens in Parkinson's disease: a double blind clinical and pharmacological study. Katzenschlager R; Evans A; Manson A; Patsalos PN; Ratnaraj N; Watt H; Timmermann L; Van der Giessen R; Lees AJ J Neurol Neurosurg Psychiatry; 2004 Dec; 75(12):1672-7. PubMed ID: 15548480 [TBL] [Abstract][Full Text] [Related]
15. Long-term safety and maintenance of efficacy of levodopa-carbidopa intestinal gel: an open-label extension of the double-blind pivotal study in advanced Parkinson's disease patients. Slevin JT; Fernandez HH; Zadikoff C; Hall C; Eaton S; Dubow J; Chatamra K; Benesh J J Parkinsons Dis; 2015; 5(1):165-74. PubMed ID: 25588353 [TBL] [Abstract][Full Text] [Related]
16. Randomized trial of IPX066, carbidopa/levodopa extended release, in early Parkinson's disease. Pahwa R; Lyons KE; Hauser RA; Fahn S; Jankovic J; Pourcher E; Hsu A; O'Connell M; Kell S; Gupta S; Parkinsonism Relat Disord; 2014 Feb; 20(2):142-8. PubMed ID: 24055014 [TBL] [Abstract][Full Text] [Related]
17. Pramipexole for the treatment of depressive symptoms in patients with Parkinson's disease: a randomised, double-blind, placebo-controlled trial. Barone P; Poewe W; Albrecht S; Debieuvre C; Massey D; Rascol O; Tolosa E; Weintraub D Lancet Neurol; 2010 Jun; 9(6):573-80. PubMed ID: 20452823 [TBL] [Abstract][Full Text] [Related]
18. A six-month study of pergolide and levodopa in de novo Parkinson's disease patients. Kulisevsky J; López-Villegas D; García-Sánchez C; Barbanoj M; Gironell A; Pascual-Sedano B Clin Neuropharmacol; 1998; 21(6):358-62. PubMed ID: 9844794 [TBL] [Abstract][Full Text] [Related]
19. Intrajejunal levodopa infusion in Parkinson's disease: a pilot multicenter study of effects on nonmotor symptoms and quality of life. Honig H; Antonini A; Martinez-Martin P; Forgacs I; Faye GC; Fox T; Fox K; Mancini F; Canesi M; Odin P; Chaudhuri KR Mov Disord; 2009 Jul; 24(10):1468-74. PubMed ID: 19425079 [TBL] [Abstract][Full Text] [Related]
20. Concurrent administration of donepezil HCl and levodopa/carbidopa in patients with Parkinson's disease: assessment of pharmacokinetic changes and safety following multiple oral doses. Okereke CS; Kirby L; Kumar D; Cullen EI; Pratt RD; Hahne WA Br J Clin Pharmacol; 2004 Nov; 58 Suppl 1(Suppl 1):41-9. PubMed ID: 15496222 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]